The Week in Review: May 11 – May 18, 2018

Friday, May 18, 2018 News Recap: Canada: Promoting Drug Pricing Policy Resources for Patient Groups. Patient groups in Canada shared in a recent survey that they struggle to understand the complexities of drug pricing policy in Canada and that they would like more information. In response, the Drug Pricing Policy Summit Working Groups have put together two web pages that outline various resources and learning opportunities to help patient groups lea...

Promoting Drug Pricing Policy Resources for Patient Groups

Patient groups in Canada shared in a recent survey that they struggle to understand the complexities of drug pricing policy in Canada and that they would like more information. In response, the Drug Pricing Policy Summit Working Groups have put together two web pages that outline various resources and learning opportunities to help patient groups learn more. Please take a look at what is available and share the links with others who would benefit. Dru

Canadian Govt. Recommends Treatment for All

New federal guidelines for all genotypes contain great news for doctors and their many patients with chronic hepatitis C (CHC) infection currently denied treatment because they cannot demonstrate liver damage of F2 (fibrosis score) or greater! Comprehensive new hepatitis C treatment guidelines have been released by the national body which recommends health policies for Canada; see https://goo.gl/xvL2HHCADTH (Canadian Agency for Drugs and Technologies in He